Thank you to Dr. Arata for speaking to the difference between CCSVI and MS. I see it as important to separate out the two so that research proceeds on the vascular side of the equation, research on a vascular treatment of a vascular disease, regardless of what is being accomplished on the neurological side of the equation. That said, I don't know if I accept the proposition that CCSVI treatment treats autonomic dysfunction and nothing more. We had a list of symptoms of CCSVI, do those all fit in the autonomic category? Fatigue, cogfog, weakness, blurred vision. I don't think cogfog is autonomic.